Call Us: 718-283- 8600
Genesis Blog
Genesis blog is up and running - September 19, 2011
Jennifer Makarov, MD joins GENESIS and will be seeing patients in Park Slope and Dyker Heights. - August 2011
Genesis announces new Park Slope, Brooklyn office - July 2011
view all posts here
Resources
Dr. David Seifer
 
   
David B. Seifer, M.D. is the Co-Director of GENESIS and Scientific Director of the Division of Reproductive Endocrinology at Maimonides Medical Center, Brooklyn, New York. Dr. Seifer received his medical degree from the University of Illinois (Chicago) Medical School and completed his residency in Obstetrics and Gynecology at Stanford University Medical Center. He subsequently completed a fellowship in Reproductive Endocrinology and Infertility at the Yale University School of Medicine.

More recently, Dr. Seifer served as a tenured Professor in the Department of Obstetrics and Gynecology and Director of Reproductive Endocrinology and Infertility at UMDNJ-Robert Wood Johnson Medical School. He is currently Clinical Professor of Obstetrics and Gynecology at New York University (NYU) School of Medicine.

Dr. Seifer is board certified in Obstetrics and Gynecology with sub-specialty certification in Reproductive Endocrinology and Infertility and has served as a Board Examiner for the American Board of Obstetrics and Gynecology in both General Obstetrics and Gynecology and the subspecialty of Reproductive Endocrinology and Infertility.

Dr. Seifer has served as a member of the editorial board for the journals Fertility and Sterility and the Journal of Pelvic Medicine and Surgery. He is also co-editor of the textbooks Clinical Reproductive Medicine, The Physiologic Basis of Gynecology, and Obstetrics, and Office Infertility: Practice and Procedures, all geared towards physician education.

He was a consultant for the Food and Drug Administration and has published extensively, with over 110 medical studies published in peer-reviewed journals. He served as a member of a National Institutes of Health (NIH) study section for a four-year term. His continuing research, which had been funded by the NIH for ten years, has focused upon the biology of ovarian function, particularly on the biological basis of the aging ovary. Dr. Seifer was a 2011 recipient of the Thomas Alva Edison Patent Award from the Research and Development Council of New Jersey and 2011 recipient of an Inventor of the Year Award from the New Jersey Inventor's Hall of Fame for his work in developing clinical testing for ovarian aging.

Dr. Seifer has been engaged in active clinical practice, including all aspects of in vitro fertilization, for almost 20 years. He has been identified by Good Housekeeping Magazine as one of the best physicians in the nation in the field of Reproductive Endocrinology and Infertility. He has been named by New York Magazine as one of the Best Doctors in the New York Metropolitan Area. The Castle Connolly Medical Guide has recognized Dr. Seifer as one of America's Top Doctors for the last 9 years. Most recently, Dr. Seifer has received a Patients' Choice award for the last four years, 2008, 2009, 2010 and 2011.

 

Dr. David Seifer

Major Award Times Two - UMDNJ Magazine Winter 2012
Researcher-physician and inventor DAVID SEIFER,MD, a clinical professor of obstetrics, gynecology and reproductive sciences at RWJMS, was honored with an Inventor of the Year Award from the New Jersey Inventors Hall of Fame in October and a Thomas Alva Edison Patent Award from the Research & Development Council of New Jersey in November. These awards are given to scientists and inventors whose patents represent the most important scientific innovations originating in the state.
Seifer was given the awards for his work in developing clinical testing to assess ovarian aging. He and colleagues discovered that Mullerian inhibiting Substance (MIS), also known as Antimullerian Hormone (AMH), is the earliest biomarker of ovarian aging. The hormone is produced by early stage ovarian follicles, declines with age and its levels can be measured with a simple blood test. The test to measure its levels is now widely used in reproductive medicine and research in more than 50 countries to assess female fertility. “Other fertility tests confirm that menopause has happened,” explains Seifer. “But AMH appears to anticipate menopause by several years,” giving women a window of opportunity for having children. “It’s useful in making clinical decisions about egg supply and a reasonable prediction of when menopause may occur.” Seifer’s co-inventor is David MacLaughlin, PhD, of Massachusetts General Hospital and Harvard Medical School.

Click Here for 2 Minute Video reguarding the 2011
Thomas Edison Patent award


Click here for Dr. Seifer's Publications
 | In the News

 
1355 84th Street, Brooklyn, NY 11228 808 8th Avenue, Brooklyn, NY 11215
1855 Richmond Avenue, Staten Island, NY 10314 1175 West Broadway, Suite 24, Hewlett, NY 11557
Copyright 2011 Genesis. All rights reserved.